AMPLATZER™ LAA Occluder Post Approval Study (PAS)

AMPLATZER™ LAA Occluder Post Approval Study

The aim of this multicenter, non-randomized observational post-approval is to compile real world outcome data on the use of an AMPLATZER LAA Occluder in subjects with non-valvular atrial fibrillation (NVAF). The AMPLATZER LAA Occluders is a transcatheter, self-expanding nitinol device intended for use in preventing thrombus embolization from the LAA.

Inclusion Criteria:

• 18 years of age or older
• Documented history of nonvalvular atrial fibrillation
• Subjects in whom an AMPLATZER LAA Occluder device is intended to be implanted or Subjects who underwent an AMPLATZER LAA Occluder implant attempt after the device was approved in the applicable geography

Exclusion Criteria:

• Women of childbearing potential who are, or plan to become, pregnant during the time of the study